The FDAs adverse event reporting system, or FAERS database, is designed to support the FDAs post-marketing safety surveillance program for drug and therapeutic biologic products
In Experiment 1, acute semaglutide robustly disrupted alcohol discrimination, as evidenced by dose-dependent reductions in alcohol-appropriate responding in both sexes
For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
There have been postmarketing reports of renal impairment, acute kidney injury, and worsening of chronic renal failure, which sometimes has required hemodialysis, in patients treated with GLP-1 receptor agonists
Avoiding these is just as important as getting the timing right
Multiple reviewers were surprised by this, expecting a flat rate throughout treatment